The EDC is live today — see what ships now
All studies
NCT07490418From ClinicalTrials.govRecruiting

TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms

TES HT100 Clinical Outcomes - Clinical Validation of the TES HT100 Temnograph for Brain Injury Screening in Patients With Mild Head Trauma or Suspected Neurological Symptoms (TESCO)

  • Mild Traumatic Brain Injury
  • Intracranial Lesions
  • Neurological Symptoms Not Related to Head Trauma

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
B&B srl
Enrolment target
850
Started
4 December 2024
Main results due
30 December 2026
Study sites
3
Registry updated
24 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Age greater than 18 years
* Provision of informed consent
* Presentation to the Emergency Department with mild head injury, or
* Presentation to the Emergency Department for non-traumatic neurological symptoms and not in a critical condition, including:
* syncope
* spatial disorientation and/or loss of balance
* speech disturbance and/or facial hemi-paresis
* visual alterations
* memory loss and/or confusional state

Exclusion Criteria:

* Age less than 18 years
* Pregnant women
* Metal plates or metal prostheses installed in the skull cap
* Severe head trauma and/or extensive lacerated-contused areas
* Critical condition
* Visible skull fracture
* Failure or inability to provide signed informed consent

What this study is about

In the sponsor’s own words, from the registry.

The goal of this clinical study is to evaluate how accurately and safely the TES HT100 device can identify intracranial abnormalities in adult emergency department patients with mild head trauma or neurological symptoms that are not related to trauma and are not immediately life-threatening. The main questions it aims to answer are:

* How well does TES HT100 identify patients with intracranial abnormalities compared with head CT, the reference standard? * Is TES HT100 safe to use in this patient population? * Could TES HT100 help improve patient triage and use of hospital resources in the emergency setting?

Researchers will compare the result of TES HT100 with the head CT report.

Participants will:

* Be enrolled if they are adults presenting to the emergency department with mild head trauma or selected neurological symptoms * Undergo standard clinical assessment and head CT according to usual care * Have an additional TES HT100 examination lasting about 5 minutes, performed by trained personnel * Be assessed for device performance and any adverse events related to use of the device

Study sites(3)

  • Pineta Grande Hospital

    Castel Volturno, CE, Italy

    Recruiting

  • Emergency Department, University Clinical Centre, Medical University of Gdańsk

    Gdansk, Poland

    Not yet recruiting

  • Emergency Department, Leszek Giec Upper Silesian Medical Centre of the Medical University of Silesia in Katowice

    Katowice, Poland

    Recruiting

Showing 3 of 3 sites. 2 of the 3 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07490418. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Sym | Trialion